PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsYabao Pharmaceutical
Yabao Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
GalantamineGalantamine2009-02-06
Alzheimer disease
MeloxicamMeloxicam2006-07-192024-2039
Rheumatoid arthritis
,
Osteoarthritis
,
Postoperative pain
SorafenibSorafenib2022-11-092023-2028
Renal cell carcinoma
,
Hepatocellular carcinoma
,
Thyroid neoplasms
CelecoxibCelecoxib2023-04-102029-2038
Ankylosing spondylitis,
Rheumatoid arthritis,
Osteoarthritis,
Adenomatous polyposis coli,
Dysmenorrhea,
Hypertension,
Coronary artery disease,
Variant angina pectoris,
Pain
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sorafenib
fasting
Bevifimod
fasting
,
critical illness
Maltodextrin
critical illness
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use